Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.

MLA

Yasuda, Kenji, et al. “Serum Active Hepatocyte Growth Factor (AHGF) in Benign Prostatic Disease and Prostate Cancer.” The Prostate, vol. 69, no. 4, Mar. 2009, pp. 346–51. EBSCOhost, https://doi.org/10.1002/pros.20890.

APA

Yasuda, K., Nagakawa, O., Akashi, T., Fujiuchi, Y., Koizumi, K., Komiya, A., Saiki, I., & Fuse, H. (2009). Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. The Prostate, 69(4), 346–351. https://doi.org/10.1002/pros.20890

Chicago

Yasuda, Kenji, Osamu Nagakawa, Takuya Akashi, Yasuyoshi Fujiuchi, Keiichi Koizumi, Akira Komiya, Ikuo Saiki, and Hideki Fuse. 2009. “Serum Active Hepatocyte Growth Factor (AHGF) in Benign Prostatic Disease and Prostate Cancer.” The Prostate 69 (4): 346–51. doi:10.1002/pros.20890.